Movement Disorders: Viewpoint—Medical Therapy

Author(s):  
Abraham N. Lieberman ◽  
Sara S. Dhanani
Author(s):  
Keyoumars Ashkan ◽  
Ismail Ughratdar

Merely having the technical ability to perform functional neurosurgery is not sufficient. An understanding of key clinical concepts surrounding movement disorders lies at the heart of becoming a competent functional neurosurgeon in order to ensure correct patient selection and perioperative management. This chapter provides a thorough medical overview of the fundamental clinical aspects, including pathophysiology, diagnosis and medical therapy for the commonest movement disorders encountered in neurosurgical practice: Parkinson’s disease, essential tremor, and dystonia. A brief overview of the surgical management options and outcomes from surgery is discussed. Finally, some of the controversies related to the surgical aspects of movement disorders are examined.


2010 ◽  
Vol 2010 ◽  
pp. 1-4 ◽  
Author(s):  
Joseph Sebeo ◽  
Stacie G. Deiner ◽  
Ron L. Alterman ◽  
Irene P. Osborn

In patients refractory to medical therapy, deep brain stimulations (DBSs) have emerged as the treatment of movement disorders particularly Parkinson's disease. Their use has also been extended in pediatric and adult patients to treat epileptogenic foci. We here performed a retrospective chart review of anesthesia records from 28 pediatric cases of patients who underwent DBS implantation for dystonia using combinations of dexmedetomidine and propofol-based anesthesia. Complications with anesthetic techniques including airway and cardiovascular difficulties were analyzed.


Author(s):  
Amy Lustig ◽  
Cesar Ruiz

The purpose of this article is to present a general overview of the features of drug-induced movement disorders (DIMDs) comprised by Parkinsonism and extrapyramidal symptoms. Speech-language pathologists (SLPs) who work with patients presenting with these issues must have a broad understanding of the underlying disease process. This article will provide a brief introduction to the neuropathophysiology of DIMDs, a discussion of the associated symptomatology, the pharmacology implicated in causing DIMDs, and the medical management approaches currently in use.


2006 ◽  
Vol 175 (4S) ◽  
pp. 488-488
Author(s):  
Folke Schmidt ◽  
Simon Ldsch ◽  
Ludger Franzaring ◽  
Joachim W. Thüroff

Sign in / Sign up

Export Citation Format

Share Document